Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aversa

Showing results (1171-1180 of 1,227) with videos related to

Pageof 123
Sort By:
BMC Cancer|November 26, 2016
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trialFrancesco Caponigro, Elena Di Gennaro, Franco Ionna, et al.
Infection and Immunity|March 30, 2021
Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic PatientsClaudio Costantini, Emilia Nunzi, Angelica Spolzino, et al.
Thorax|June 3, 2020
Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort studyMichaela R Anderson, Imaani Easthausen, Grace Gallagher, et al.
Haematologica|October 24, 2009
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry studyLivio Pagano, Morena Caira, Anna Candoni, et al.
Cell Death & Disease|June 17, 2022
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemiaAnna Montanaro, Samuel Kitara, Elisa Cerretani, et al.
Annals of Hematology|February 8, 2018
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL)Roberta Di Blasi, Chiara Cattaneo, Russell E Lewis, et al.
Cancer Research|January 19, 2018
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAFWenlin Shao, Yuji M Mishina, Yun Feng, et al.
Cell Chemical Biology|May 11, 2020
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic LeukemiaMatteo Marchesini, Andrea Gherli, Anna Montanaro, et al.
International Journal of Molecular Sciences|July 12, 2025
Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN ExpressionMarta Garcia de Herreros, Natalia Jiménez, Joan Padrosa, et al.
European Journal of Cancer (Oxford, England : 1990)|November 17, 2021
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocolJ Stutterheim, P de Lorenzo, I M van der Sluis, et al.
Pageof 123

Showing results (1171-1180 of 1,227) with videos related to

Sort By:
Pageof 123
BMC Cancer|November 26, 2016
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trialFrancesco Caponigro, Elena Di Gennaro, Franco Ionna, et al.
Infection and Immunity|March 30, 2021
Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic PatientsClaudio Costantini, Emilia Nunzi, Angelica Spolzino, et al.
Thorax|June 3, 2020
Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort studyMichaela R Anderson, Imaani Easthausen, Grace Gallagher, et al.
Haematologica|October 24, 2009
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry studyLivio Pagano, Morena Caira, Anna Candoni, et al.
Cell Death & Disease|June 17, 2022
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemiaAnna Montanaro, Samuel Kitara, Elisa Cerretani, et al.
Annals of Hematology|February 8, 2018
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL)Roberta Di Blasi, Chiara Cattaneo, Russell E Lewis, et al.
Cancer Research|January 19, 2018
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAFWenlin Shao, Yuji M Mishina, Yun Feng, et al.
Cell Chemical Biology|May 11, 2020
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic LeukemiaMatteo Marchesini, Andrea Gherli, Anna Montanaro, et al.
International Journal of Molecular Sciences|July 12, 2025
Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN ExpressionMarta Garcia de Herreros, Natalia Jiménez, Joan Padrosa, et al.
European Journal of Cancer (Oxford, England : 1990)|November 17, 2021
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocolJ Stutterheim, P de Lorenzo, I M van der Sluis, et al.
Pageof 123